Relapses with a target-Ag-negative clone may occur by immune-editing resulting in the selection of a pre-existing Ag-negative subclone, or possibly by acquired loss of the target-Ag that was initially expressed by the tumor cells. The gene discussed is RENBP; the disease is neoplasm.